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Abstract: The modulation of host antimicrobial activity by antibiotics is of therapeutic
importance. The effect of serum on drug activity is also of clinical interest. We studied the
effect of roxithromycin on the opsonizing time of plasma and the oxygen consuming activity
of phagocytes in peripheral whole blood that reflects in vivo bacteremia more than isolated
serum and granulocytes. Roxithromycin has no effect on the opsonizing activity at any
concentrations we examined. At lower concentration (<50ƒÊg/ml), roxithromycin does not
give any effects on zymosan-stimulated oxygen consumption either. At the highest concen-
tration (200ƒÊg/ml) we examined, the antibiotic however decreases it to the extent compara-
ble to that reported in serum-free reconstituted in vitro system. These results indicate that
roxithromycin has modulatory effects neither on anti-microbial oxygen metabolism of
phagocytes nor on the opsonizing activity of plasma at pharmacological concentration, but is
inhibitory on the former at its toxic concentration. On the other hand, serum proteins have
no effects on drug toxicity in this context in comparison to in vitro studies (24, 30).
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INTRODUCTION
Humanpolymorphonuclear leukocytes (PMN) generate reactive oxygen species such as
superoxide anion (7), hydrogen peroxide (15, 25), and hydroxyl radical (26, 29) from molecular
oxygen by a biochemical pathway called respiratory burst (8). This nonmitochondrial respi-
ration is essential for PMN to kill phagocytosed bacteria (5, 6, 9, 12, 14, 27). Any modula-
tions of this activity by antimicrobial agents may directly influence host defense system.
Certain antimicrobial agents such as cefodizime and cefpimizole are known to potentiate
phagocytotic killing of bacteria (22, 23). Conflicting reports have been published regarding the
effect of erythromycin on the phagocytosis by PMN (17, 18, 30). Roxithromycin, a C-9 oxime
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derivative of erythromy℃in (21, 24), achieves siμnifi℃ant intra℃ellular ℃〇n℃entration (13) and
remains effective against mi℃r〇bes in the Cells (3, 10). With the notion that serum proteins
redu℃e antiba℃terial activity of roxithromy℃in (4) and ℃i℃letanine which is lipid-soluble and
binds to erythr〇℃ytes (32), we have assumed roxithr〇my℃in μives a different effect on
phaμo℃yt〇sis-℃〇nne℃ted oxygen ℃onsupmti〇n in vivo and in vitro. We have aimed here to
make Clear the effect 〇f the drug 〇n the opsomzmμ activity 〇f plasma and the respiratory
.　　　　･
burst by phagocytes stimulated with zymosan in whole blood that reflects in vivo condition.
MATERIALS AND METHODS
phagocytes: Heparinized fresh blood from healthy adults was mixed by gentle agitation
with two volumes of air and one volume of ℃〇 gas in a syrmμe for repla℃inμ 〇2 bound to
･
hem〇μ1〇bin to ℃〇. This procedure makes an oxygen ele℃tr〇de spe℃ifi℃ally monitor
phaμo℃yt〇sis-℃〇nne℃ted oxygen ℃onsumpti〇n in the bl〇〇d (16)･
Reagents: Roxithromycin (Eisai Co., Ltd., Tokyo, Japan) was dissolved in dimethyl sul-
f〇xide (DMS〇) to μive a st〇℃k solution of lO〇喝/ml. The final ℃on℃entration of the antibiotic
in diluted whole blood was varied as shown in Resuts, and that of DMS〇 was fixed t〇 0.2%
(v/v). other reaμents used were all in analytical μrade･
simultaneous assays of phagocyctosis-connected oxygen consumption and opsonizing activity
of plasma: CO-treated whole blood (0.33ml) was diluted with 2 volumes of phosphate buffered
saline (PBS, 120 mM Na℃1, 5mM K℃1, 5mM μ1u℃〇se, ImM Mμ℃k 0.5mM ℃a℃12, and 17 niM
sodium phosphate, pH 7.3) and preincubated with or without Roxithromycin for 10 min in a
sili℃onized Eppend〇rf tube at 37℃･ The diluted blood was transferred to a water-ia℃keted
assay well with a fitted oxygen ele℃tr〇de and was kept Constantly stirred at 37℃ throuμh〇ut
the experiment. The net volume of the assay well ℃1〇sed with a screw ℃ap was 〇･6ml. The
oxyμen ℃on℃entration of the assay well was ℃〇ntinuously monit〇red at 37℃ on a National
M〇del VP6163B re℃〇rder (Matsushita ℃o･, Ltd･ Osaka, Japan). One square on a Chart was
adjusted to reflect lμM of oxygen with an assumption that oxygen ℃on℃entration in air-
equilibrated water is 217 μM at 37℃. For the stimulation of phaμ〇℃ytes, 3〇μ1 of s〇ni℃ated
suspension (60喝ノml) of zymosan A (Siμma, St. Louis, USA･) was added t〇 the well by a
mi℃r〇syrmμe (2〇). A lag time before the appearance 〇f the oxygen Consumption by phaμo.
cytes was used as an opsonizing time because it reflects opsonizing activity of plasma (19).
phagocytosis-connected oxygen consumption was calculated from the linear portion of
de℃rease in oxygen ℃On℃entration (Fig. 1)･
statisti℃ul analツ<ses: All data were examined by Student's t test, and their siμnifi℃an℃e
was determined positive when p was less than 〇･05. Each value a℃℃ompanies one standard




Fiμ. 1. Phaμ〇叫osIS-℃onne℃ted oxyμen Consumption in whole bio〇d stimulated
by the addition of unopsonized (A) 〇r ops〇nized (B) Zym〇san. Zymosan
was added t〇 the well equipped with an 〇Ⅹyμen electrode at the time
mdi℃ated by an arrow. 〇psomzmμ time is equivalent to the lag time for
the apparent appearance of 〇=yμen ℃〇nsumpti〇n which is induced by
the addition of unopsonized Zymosan to 33.3% whole blood (19).
RESULTS
R〇xithromy℃in does not ℃hanμe the 〇ps〇mzmμ activity re鮎℃ted by a lag time for the
appearan℃e of the siμnifi℃ant oxygen ℃〇nsumption by phaμo℃ytes at any ℃on℃entrati〇ns up to
●
2〇Oμμノml (Tables 1 and 2). Added zymosan is ℃〇n℃luded to be opsonized to the same extent
in the presence and absence of the antibiotic Therefore oxygen ℃〇nsumpti〇n stimulated with
the addition of zym〇san in whole bl〇〇d ℃an directly re鮎℃t the respiratory burst of phaμ〇.
℃昨s in the whole blood. The effect of the antibiotic on the oxygen Consumption by stimu-
lated phaμ〇℃沖s ℃an be therefore ℃al℃ulated from the same assays used for the lag times.
Phaμo℃ytosis-℃onne℃ted oxygen Consumption without roxithromy℃in is 4.3 nmoles 〇2/minノ1〇6
℃ells. (Fig. 2)･ In the presence 〇f lower ℃on℃entration of roxithr〇my℃in (1･56-25μ μ/ml), the
oxyμen ℃〇nsumption by stimulated phaμ〇℃昨s varies 4･3 - 5.1 nmoles 〇2/minノ1〇6 Cells (Fig.
2), which is not s郎ifi℃antly different each Other. The Consumption, however, has a tendency
to gradually decrease in the increase in the ℃on℃entration 〇f the drug (50-2〇Oμ μ/ml) (Fig.
3)･ At its hiμbest ℃on℃entrati〇n (2〇Oμ μ/ml), r〇xithr〇my℃in has siμnifi℃antly (p<〇･〇5)
de℃reased phaμo℃ytosis-℃onne℃ted 〇Ⅹyμen Consumption t〇 61±21% (n-3, Fig. 3) in diluted
whole blood, and to 48±8% (n-3) in an artificial buffer Only.
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Table 1. Effect of roxithromy℃in on opsonizmμ activity 〇f plasma at lower ℃on℃entration at 37℃. The
result represents mean ±S. D. of three assays.
Table 2. Effect of r〇xithromy℃in on serum ops〇nizmμ activity at higher ℃on℃entration at 37℃. The
result represents mean ± S. D. of three assays.
Fig. 2. Effect of roxithromycin at lower concentration on oxygen consumption
by phaμo℃ytes stimulated with zymosan at 37℃. Each Column







Fig. 3･ Effect of roxithromy℃in at hiμher ℃on℃entration on oxygen ℃onsumpti〇n
by phaμo叫es stimulated with zymosan at 37℃, Each point with a bar
represents mean ± S. D. of three assays.
A　,
DIS℃USSION
P〇tential ℃〇operation between an antibiotic and the immune system is parti℃　im-
p〇rtant in patients with severe infectious diseases and impaired immune function su℃k as
a℃quired immune defi℃ien℃y syndrome.
We used here whole bl〇〇d to quantitate opsonizinμ activity of plasma and respirat叩
burst 〇f peripheral phaμ〇℃ytes for making our assays reflect in vivo Condition and for
avoidinμ any artifacts that may 〇℃℃ur during preparation of plasma and phaμo℃ytes. Neu-
trophils purified from normal peripheral bl〇〇d are slightly stimulated or primed to generate
･
superoxide anions in the or〇℃edure of ℃ell preparation. In fact, ℃yto℃hrome b558 mostly
present in membrane 〇f spe℃ifi℃ granules is transferred to the surface ℃沖plasmi℃ membrane
during preparation of purified neutrophils (ll).
The respiratory burst of phaμo℃ytes and the 〇ps〇nizmμ activity of plasma ℃an be
･
.　　　.
simultane〇usly assayed by m〇nit〇rlnμ OXyμen Consumption or ℃hemilumines℃en℃e resp〇nse･
･
The latter technique was not used here because 〇f foil〇wlnμ two reasons. Dilution of whole
●
blo〇d for optimal opsonization of zym〇san is not enough for avoiding quen℃hinμ of light by
red blood Cells (2, 16), and ℃hemilumines℃en℃e intensity depends 〇n the adhesion activity 〇f
phaμo℃ytes as well as respiratory burst itself (31).
Although we could not demonstrate statistically significant difference between the in-
.
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hibitory extents of respiratory burst by roxithromy℃in in whole bl〇〇d and in buffer system
.
(f-1.56 with--the degree 〇f freedom at 4), Certain difference might be found in further ex-
periments. R. Anderson; (1) observed the inhibit!〇n by roxithromy℃in of lu℃iμenin enhanced
℃hemilumines℃en℃e (LE℃L) response 〇f neutr〇phils stimulated with opsonized zymosan. The
inhibit〇ry e坤nt 〇f them is ℃〇mparable t〇 Ours (Fig. 3)･ We speculated serum binding pro.
壬
tiens and red bl〇〇d Cells Could have reduced the effective ℃〇n℃entration 〇f the dmμ and thus
redu℃inμ the inhibit〇ry activity of the dr噸on oxygen metabolism of phaμo℃ytes and pro-
te℃tinμ them from drug t〇Ⅹi℃i吋･
A℃tivities of Complement Components as a whole was not impaired by the antibiotic,
suggesting both classical and alternative pathways are kept intact (28). As roxithromycin has




does not modulate the respiratory burst at therapeutic ℃on℃entrati〇n. It however inhibits the
respiratory burst at supratherapeuti℃ ℃〇n℃entrati〇n. Therefore phaμ〇℃yte NADPH 〇xidase
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